Close Menu

NEW YORK – An international team of researchers has developed a polygenic risk score for glaucoma that could help identify people who are at risk of developing the condition at an earlier age and may benefit from earlier screening and treatment.

Glaucoma is the leading cause of blindness across the globe, and though there is no cure, there are treatments to slow or stop vision loss. But once vision is gone, it cannot be restored, meaning that early detection is important to prevent disease progression.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A German shepherd called Nala has had her genome sequenced.

A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?

Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.

In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.